Anvisa aprova primeiro medicamento de GLP-1 oral para obesidade
Safety Classified by Officially
Produto é indicado para tratamento de perda e manutenção do peso em adultos
Read the original at the source: https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2026/anvisa-aprova-primeiro-medicamento-de-glp-1-oral-para-obesidade
Officially imported this from Agência Nacional de Vigilância Sanitária (Anvisa)’s own source. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
This publication has changed since it was first published
2 versions recorded. The original is kept in full — nothing is overwritten.
- v2 imported change on current
- v1 as first published on
Provenance
- Organization
- Agência Nacional de Vigilância Sanitária (Anvisa) — imported from official source
- Official source
- https://www.gov.br/anvisa/++api++/@search?portal_type=News%20Item&sort_on=effective&sort_order=reverse&b_size=25&metadata_fields=effective&metadata_fields=UID API
- Imported
- November 04, 2026 09:01
- Versions
- 2 recorded
- Identity
-
13f774ce8dd5492f8416c49b35cb549f